Group News_Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Group Introduction

Corporate Culture

Heritage of Ingenuity

Heritage of Ingenuity

Products and Services

Health Information

Investor Relations

Stock Information

Company Announcements

Investor Contact

Recruitment Information

Tianjin Pharma DRT (SH600329)

35.17 +0.35 +1.01%

中文 English

Group Introduction History Corporate Culture Group Industry ESG Brand Display

Heritage of Ingenuity

Product Family Products and Services

Health Information Media Coverage

Investor Relations

Stock Information Company Announcements Investor Contact

Talent Concept Recruitment Information

Online Mall

Latest news

Group News

Home Page Group News

达仁堂现代中药贴剂成果引业内关注

作为制药行业年度重要盛会，日前，CPI 2026京津冀制药工业大会暨制药全产业链资源对接大会在京举行。

AI助力产品线上销售——探秘ChatGPT与SORA的神奇力量

津药达仁堂组织开展大健康产品受托生产企业审计工作

津药达仁堂集团“三无一全”家族添加新成员——黄连、厚朴基地顺利通过现场核查

多维联动立体传播，精彩霸屏亿级曝光

媒体关注 | 津药达仁堂聚焦新质生产力，为中医药发展注入新动力

津药达仁堂集团第六中药厂获5项国家专利授权

We are the Leader of Chinese Medicine and Striving to Become a Leader in Innovative Medicine in China

Heritage of Ingenuity

Investor Relations

Address: 78 Shenton Way, #19-02

Singapore：079120

Tel：+65 6514 0579

Fax：+65 6514 0439

JICPB No. 2022007352 JGWAB No.12010402000399

Internet Drug Information Service Qualification Certificate No.: (Tianjin) - Non operational -2020-0021

© 2023 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Powered by xinhongru.

Privacy Policy Legal Statement